Chapter 5. Unravelling Biological Pathways and the Identification of Clinical Markers and Targets in Renal Cancer

  1. Dr. Jean-Charles Sanchez,
  2. Dr. Garry L. Corthals,
  3. Prof. Dr. Denis F. Hochstrasser
  1. Rosamonde E. Banks,
  2. Peter J. Selby

Published Online: 20 SEP 2004

DOI: 10.1002/3527601562.ch5

Biomedical Applications of Proteomics

Biomedical Applications of Proteomics

How to Cite

Banks, R. E. and Selby, P. J. (2004) Unravelling Biological Pathways and the Identification of Clinical Markers and Targets in Renal Cancer, in Biomedical Applications of Proteomics (eds J.-C. Sanchez, G. L. Corthals and D. F. Hochstrasser), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, FRG. doi: 10.1002/3527601562.ch5

Editor Information

  1. Biomedical Proteomics Research Group, Laboratoire Central de Chimie Clinique, Hopitaux Universitaires de Genève, 24, rue Micheli-du-Crest, 1211 Genève 14, Switzerland

Author Information

  1. Cancer Research UK Clinical Centre, St. James's University Hospital, Beckett Street, Leeds LS9 7TF, United Kingdom

Publication History

  1. Published Online: 20 SEP 2004
  2. Published Print: 27 JAN 2004

ISBN Information

Print ISBN: 9783527308071

Online ISBN: 9783527601561

SEARCH

Keywords:

  • renal cancer;
  • clinical markers and targets;
  • immunotherapy;
  • proteomic studies

Summary

  • Renal Cancer – The Clinical Perspective

    • Epidemiology

    • Current Clinical Approaches and Clinical Challenges

    • Immunotherapy for Renal Cancer

    • Existing Markers or Therapeutic Targets Undergoing Clinical Evaluation

  • Proteomic Studies

    • Tissue-based Studies

    • Primary and Established Cell Lines

    • Biological Fluids

  • Conclusions

  • References